Cardura XL (doxazosin) extended release tablets 8mg, 30-count bottles, Rx Only Made in Singapore,...

FDA Recall #D-0603-2024 — Class II — April 30, 2024

Recall #D-0603-2024 Date: April 30, 2024 Classification: Class II Status: Completed

Product Description

Cardura XL (doxazosin) extended release tablets 8mg, 30-count bottles, Rx Only Made in Singapore, Distributed by Roerig Division of Pfizer Inc, NY, NY 10017 NDC 0049-2080-10

Reason for Recall

Failed Impurities/Degradation Specifications

Recalling Firm

Viatris Inc — Canonsburg, PA

Classification

Class II — May cause temporary or medically reversible adverse health consequences.

Product Type

Drugs

Product Quantity

3,694 bottles

Distribution

U.S. Nationwide

Code Information

Lot#: 8147041; Exp. June 2024 Lot#: 8163765; Exp. March 2025

Status

Completed

Voluntary / Mandated

Voluntary: Firm initiated